YAP1 and familial pancreatic carcinoma: Similarly, YAP1 upregulates PD-L1 transcription in EGFR-TKI-resistant lung adenocarcinoma (LUAD) cells,93 yet in pancreatic cancer, DCLK1 suppresses PD-L1 via the Hippo pathway, highlighting tissue-specific regulatory circuits.94